Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.

Abida, Wassim

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 06 2020 - 2487-2496 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Comment

1557-3265

10.1158/1078-0432.CCR-20-0394 doi


DNA Damage
Humans
Indoles
Male
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use
Prospective Studies
Prostatic Neoplasms, Castration-Resistant--drug therapy